GREGORY THOMAS SMITH

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease PITTSBURGH, PA NPI 1083608947

General Payments — all program years on this page

$2,646.26

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 136
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $419.21 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $419.2118

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CVRx Inc. $112.965
Boehringer Ingelheim Pharmaceuticals, Inc. $85.873
Esperion Therapeutics, Inc. $69.513
Amgen Inc. $66.053
PFIZER INC. $64.443
Acerta Pharma LLC $20.381

By program year

Program yearAmountRecords
2018 $305.1118
2019 $253.6814
2020 $383.9620
2021 $349.9220
2022 $556.0429
2023 $378.3417
2024 $419.2118

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105547987 AstraZeneca Pharmaceuticals LP $20.38 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111711808 Amgen Inc. $23.70 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111711810 Amgen Inc. $22.77 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111711812 Amgen Inc. $19.58 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117865601 Boehringer Ingelheim Pharmaceuticals, Inc. $22.54 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117865603 Boehringer Ingelheim Pharmaceuticals, Inc. $28.14 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117865605 Boehringer Ingelheim Pharmaceuticals, Inc. $35.19 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129456016 Esperion Therapeutics, Inc. $21.33 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129456018 Esperion Therapeutics, Inc. $23.48 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129456020 Esperion Therapeutics, Inc. $24.70 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131051162 PFIZER INC. $26.63 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131285419 PFIZER INC. $16.87 03/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131343701 PFIZER INC. $20.94 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138615145 CVRx, Inc. $19.90 01/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138615147 CVRx, Inc. $23.11 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138615149 CVRx, Inc. $24.18 04/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138615151 CVRx, Inc. $22.69 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138615153 CVRx, Inc. $23.08 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.